Les dernières actualités et mises à jour sur Other provenant de sources fiables du monde entier.
An experimental mRNA vaccine has shown early promise in a phase 1 trial involving patients with pancreatic cancer, one of the deadliest and most difficult cancers to treat. Researchers said the…
An updated personalized mRNA cancer vaccine has shown encouraging results in melanoma, reducing the risk of recurrence or death by 44% versus standard immunotherapy alone, according to interim Phase…
Researchers have reported encouraging early results for an experimental mRNA vaccine aimed at pancreatic cancer, one of the deadliest and hardest-to-treat cancers. In a small clinical trial, the…
Researchers say an experimental mRNA vaccine has shown encouraging early results in a phase 1 trial, with the potential to target more than one type of cancer. The study, reported by Reuters,…
